Flash Chesco Stock Alert

By

Don’t look now but shares of Fibrocell (FCSC: NYSE), the Exton-based company focused on developing treatments for rare and serious skin and connective tissue damage and diseases, are up 41-percent in the last 30 days.

7.2.2014 Fibrocell

Previous coverage of Fibrocell on Chesco Business Today here and here.

 

Tags: , ,

Connect With Your Community

Subscribe to stay informed!

"*" indicates required fields

This field is hidden when viewing the form
VT Yes
Advertisement

You Might Also Like

Female scientist working with test tubes.Pharma & Biotech

Wayne’s Palvella Therapeutics Completes Reverse Merger with Pieris Pharmaceutical

tablets and pills spread out on a table.Pharma & Biotech

Former CEO Launches Wayne-based Enginuity Rx, Integrated Provider of End-to-End Digital Care 

verrica pharmaceuticals signPharma & Biotech

West Chester-based Verrica Pharmaceuticals Expects to Raise $42 Million in Public Stock Offering 

man and woman in laboratoryPharma & Biotech

Wayne’s Aclaris Therapeutics Signs Exclusive Licensing Deal with Chinese Biotech